OPUS GENETICS INC
IRD·67577R102·US·Common Stock·Healthcare - Biotechnology-Activist
IRD (OPUS GENETICS INC) is held by 44 institutional investors as of Q1 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($27.4M), BALYASNY ASSET MANAGEMENT L.P. ($12.4M), MILLENNIUM MANAGEMENT LLC ($12M). Net institutional sentiment: Mixed.
44
Holders
Avg rating(10 Elite)
$103.1M
Total Value
65% (48)
Fund Consensus
26 buying - 14 selling
Who's Trading
ActivistFFFoundation Fighting Blindness Retinal Degeneration Fund4.7%May 20, 2026
InsiderFFFoundation Fighting Blindness Retinal Degeneration FundSell $7.4MMay 18, 2026
ActivistNANantahala Capital Management, LLC6.5%May 15, 2026
ActivistPAPerceptive Advisors LLC10.0%May 15, 2026
ActivistCACaligan Partners LP8.5%May 15, 2026
ActivistADAdage Capital Management, L.P.8.5%May 13, 2026
InsiderMGMagrath GeorgeSell $50KApr 23, 2026
InsiderYRYERXA BENJAMIN RSell $39KApr 23, 2026
InsiderGEGagnon Robert E.Sell $41KApr 23, 2026
13F: Insider & Congress:
Showing 1-20 of 48
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer